Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 139 of 1,261
  1. US 11891638

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Northwestern University Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  2. US 11891426

    CD19 variants

    Regents of the University of Minnesota Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  3. US 11890289

    Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

    Corcept Therapeutics Incorporated Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  4. US 11891626

    Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue

    DiscGenics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  5. US 11891442

    Compositions and methods for treating age-related diseases

    United States Government as represented by the Department of Veterans Affairs Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  6. US 11890415

    Airway management systems for pulmonary disorder treatment

    Covidien LP Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  7. US 11890285

    Combination therapies

    Mirati Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  8. US 11891628

    Method for biomimetic culture of urothelial cells and uses thereof

    China Medical University Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  9. US 11890281

    SHP2 phosphatase inhibitors and methods of making and using the same

    Relay Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  10. US 11891393

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  11. US 11890290

    Topical treatment of wounds with statins and cholesterol for scar reduction

    Northwestern University Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  12. US 11891431

    Removal of serine proteases by treatment with finely divided silicon dioxide

    Takeda Pharm Limited ceutical Company Limited Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  13. US 11891389

    PGDH inhibitors and methods of making and using

    Myoforte Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  14. US 11890346

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein

    Northwestern University Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  15. US 11890340

    Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  16. US 11890308

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  17. US 11890272

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  18. US 11890225

    Devices and methods for slurry generation

    MIRAKI INNOVATION THINK TANK LLC Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  19. US 11890306

    Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same

    Finch Therapeutics Holdings LLC Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  20. US 11890339

    Nipah virus immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  21. US 11892452

    Disease-associated antigens and methods of use thereof

    The Regents of the University of California Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  22. US 11891360

    Glycosylated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  23. US 11892450

    Evaluation, assays and treatment of pKal-mediated disorders

    Takeda Pharmaceutical Company Limited Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  24. CA 3259243

    POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE BCL-2

    RYVU THERAPEUTICS S A [PL] Β· Granted Feb 1, 2024 Β· Expires Jan 27, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.